HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enza Lacivita Selected Research

Amino Acids

1/2014Prepuberal stimulation of 5-HT7-R by LP-211 in a rat model of hyper-activity and attention-deficit: permanent effects on attention, brain amino acids and synaptic markers in the fronto-striatal interface.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Enza Lacivita Research Topics

Disease

8Inflammation (Inflammations)
12/2023 - 11/2017
8Neuroinflammatory Diseases
01/2022 - 07/2016
5Neoplasms (Cancer)
04/2023 - 04/2014
5Fragile X Syndrome (Martin Bell Syndrome)
05/2021 - 12/2012
4Rett Syndrome (Rett's Disorder)
01/2021 - 10/2014
3Autism Spectrum Disorder
02/2022 - 11/2017
3Central Nervous System Diseases (CNS Diseases)
01/2022 - 02/2011
2Schizophrenia (Dementia Praecox)
02/2024 - 10/2018
2Mood Disorders (Mood Disorder)
04/2023 - 10/2013
2Neuralgia (Stump Neuralgia)
04/2023 - 10/2017
2Neurodegenerative Diseases (Neurodegenerative Disease)
04/2023 - 01/2022
2Alzheimer Disease (Alzheimer's Disease)
12/2021 - 07/2016
2Neurodevelopmental Disorders
08/2020 - 07/2017
2Mitochondrial Diseases (Mitochondrial Disease)
01/2019 - 07/2017
2Sleep Wake Disorders
11/2015 - 01/2014
2Hyperalgesia
01/2014 - 11/2011
1Bacterial Infections (Bacterial Infection)
12/2023
1Stomach Neoplasms (Stomach Cancer)
12/2023
1Rheumatoid Arthritis
04/2023
1Ischemia
04/2023
1Leukemia
04/2023
1Osteoarthritis
04/2023
1Psychotic Disorders (Schizoaffective Disorder)
02/2022
1Autistic Disorder (Autism)
01/2022
1Intellectual Disability (Idiocy)
01/2021
1Neuroblastoma
12/2020
1Rare Diseases (Rare Disease)
08/2020
1CDKL5 deficiency disorder
01/2019
1Neurogenic Inflammation
01/2018
1Prostatic Neoplasms (Prostate Cancer)
01/2017
1Facial Pain (Myofacial Pain)
05/2016
1Cognitive Dysfunction
02/2016
1Hypotension (Low Blood Pressure)
04/2015
1Lung Neoplasms (Lung Cancer)
02/2015
1Depressive Disorder (Melancholia)
07/2014
1Breast Neoplasms (Breast Cancer)
04/2014
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2014
1Migraine Disorders (Migraine)
11/2011

Drug/Important Bio-Agent (IBA)

12Serotonin (5 Hydroxytryptamine)IBA
02/2022 - 02/2011
10serotonin 7 receptorIBA
02/2022 - 02/2011
8Formyl Peptide Receptors (Formyl Peptide Receptor)IBA
12/2023 - 07/2016
8Serotonin ReceptorsIBA
01/2021 - 12/2012
6Peptides (Polypeptides)IBA
12/2023 - 02/2015
6LigandsIBA
01/2022 - 04/2014
4Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
05/2021 - 12/2012
4N- (4- cyanophenylmethyl)- 4- (2- diphenyl)- 1- piperazinehexanamideIBA
10/2017 - 01/2014
3Bombesin Receptors (Bombesin Receptor)IBA
01/2018 - 02/2015
2CytokinesIBA
04/2023 - 01/2021
2Neuroprotective AgentsIBA
01/2022 - 01/2014
2Amyloid (Amyloid Fibrils)IBA
12/2021 - 07/2016
2Proteins (Proteins, Gene)FDA Link
06/2021 - 04/2014
2Antidepressive Agents (Antidepressants)IBA
10/2018 - 10/2013
1Antipsychotic Agents (Antipsychotics)IBA
02/2024
1GTP-Binding Proteins (G-Protein)IBA
12/2023
1IsoflavonesIBA
12/2023
1Adenosine Triphosphate (ATP)IBA
04/2023
1CationsIBA
04/2023
1Purinergic P2X7 ReceptorsIBA
04/2023
1AntioxidantsIBA
02/2022
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
02/2022
1lipoxin A4IBA
01/2022
1Amyloid beta-PeptidesIBA
12/2021
1Cyclin-Dependent Kinase 5IBA
05/2021
1InflammasomesIBA
01/2021
1Histones (Histone)IBA
01/2021
1Co-Repressor ProteinsIBA
01/2021
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
01/2020
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2020
1LipoxinsIBA
01/2020
1LipidsIBA
01/2020
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2019
1Capsaicin (Zostrix)FDA Link
01/2018
1Calcitonin (Calcitonin, Eel)FDA LinkGeneric
01/2018
1SB 269970IBA
01/2018
14- (2- methylthiophenyl)- N- (1,2,3,4- tetrahydronaphthalen- 1- yl)- 1- piperazinehexanamideIBA
01/2018
1IntegrinsIBA
01/2018
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2017
1Vasopressins (Vasopressin)IBA
11/2017
1Oxytocin (Pitocin)FDA LinkGeneric
11/2017
1LipopolysaccharidesIBA
11/2017
1Cyclic NucleotidesIBA
10/2017
1BombesinIBA
01/2017
1Carbon-11IBA
07/2016
1Analgesics (Analgesic Drugs)IBA
05/2016
1Formaldehyde (Formol)FDA Link
05/2016
1SB 399885IBA
04/2015
1Ergotamine (Ergotamine Tartrate)FDA LinkGeneric
04/2015
1Tyrosine (L-Tyrosine)FDA Link
02/2015
1bombesin receptor subtype 3IBA
02/2015
1Morphine (MS Contin)FDA LinkGeneric
01/2014
1Amino AcidsFDA Link
01/2014
1N-Methylaspartate (NMDA)IBA
01/2014

Therapy/Procedure

4Therapeutics
06/2021 - 04/2014
2Drug Therapy (Chemotherapy)
04/2023 - 11/2017